Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Earnings

Kits Eyecare estimates 2025 revenue of $202.5-million

KITS · Price

Executive Summary

  • Kits Eyecare Ltd. released selected preliminary unaudited Q4 2025 and full‑year 2025 financial highlights, showing strong revenue growth and expanding margins.
  • Total revenue rose 20% YoY to ~​$53.9 M in Q4 and 27% YoY to ~​$202.5 M for the full year, indicating robust top‑line performance.
  • Adjusted EBITDA margin improved to roughly 4–5% in Q4 and 5–6% for the year, reflecting improving profitability alongside higher glasses revenue and unit sales.

Key Details

  • Q4 2025 Revenue: Approximately $53.9 million, up 20% YoY.
  • Adjusted EBITDA Margin (Q4): Approximately 4.0‑5.0% of revenue.
  • Glasses Revenue (Q4): $8.7 million, up ~33% YoY.
  • Glasses Units Sold (Q4): 119,000 units, up 43% YoY.
  • Full‑Year 2025 Revenue: Approximately $202.5 million, up 27% YoY.
  • Adjusted EBITDA Margin (FY): Approximately 5.0‑6.0% of revenue.
  • New Customer Additions (FY): ~393,000, up 30% YoY.
  • Future Reporting: Audited Q4 and full‑year results to be released in early March 2026; conference call details to be disclosed in February 2026.
Read the original news release →

More from Kits Eyecare Ltd